For patients with gout and type 2 diabetes, sodium-glucose cotransporter 2 inhibitors (SGLT2is) may reduce the need f ...
Researchers compared the efficacy of febuxostat for lowering serum urate levels among patients with gout with vs without chronic kidney disease.
Sobi® (STO: SOBI) and Arthrosi Therapeutics, Inc. (Arthrosi) announced today the completion of the acquisition of Arthrosi by Sobi.
Swedish Orphan Biovitrum AB (publ) Sobi (STO: SOBI) and Arthrosi Therapeutics, Inc. (Arthrosi) announced today the completion of the acquisition of Arthrosi ...
Patients with gout who achieve a serum urate level lower than 6 mg/dL demonstrated a lower 5-year risk for cardiovascular ...
New research indicates that a drug commonly prescribed for gout may also lower the risk of heart attack and stroke when taken ...
High uric acid levels can quietly lead to joint pain, gout and kidney issues if ignored. These 5 natural remedies can help keep uric acid levels in check.
A groundbreaking new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can ...
In patients starting gout medication, hitting a target serum urate level below 6 mg/dL reduces the risk of major ...
Gout is a painful form of arthritis caused by high levels of uric acid in the blood. When too much uric acid builds up, it ...
Use of glucose-lowering SGLT2i drugs may help patients with gout and diabetes take fewer medications
Gout, a type of inflammatory arthritis caused by a buildup of uric acid (urate) in the body, affects 5.1% of U.S. adults ...
I’ve always been very open about being a big fan of vaccines. Not because of politics or blind faith, but because the evidence – accumulated over decades – overwhelmingly shows their benefits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results